Gwang-Cheol Park
Chief Executive Officer at Premierbio Co., Ltd.
Gwang-Cheol Park active positions
| Companies | Position | Start | End |
|---|---|---|---|
Premierbio Co., Ltd.
 Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Chief Executive Officer | - | - |
Career history of Gwang-Cheol Park
Former positions of Gwang-Cheol Park
| Companies | Position | Start | End |
|---|---|---|---|
| DSK CO., LTD. | Chief Executive Officer | 30/03/2016 | - |
| Chairman | 30/03/2016 | - | |
| HYUNDAI SECURITIES CO LTD | Director/Board Member | 21/06/2010 | - |
| Independent Dir/Board Member | 21/06/2010 | - |
Training of Gwang-Cheol Park
| Konkuk University | Doctorate Degree |
Statistics
International
| South Korea | 5 |
Operational
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Finance | 2 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DSK CO., LTD. | Electronic Technology |
| Private companies | 2 |
|---|---|
KB Securities Co., Ltd
 KB Securities Co., Ltd Investment ManagersFinance KB Securities Co., Ltd (KB Securities) is a private equity subsidiary of KB Financial Group, Inc. founded in 1962. The firm is headquartered in Seoul, South Korea. | Finance |
Premierbio Co., Ltd.
Premierbio Co., Ltd. Pharmaceuticals: OtherHealth Technology Premierbio Co., Ltd. is engaged in developing Protoxin. It offers development and supply of Botulinum type A Toxin. The company was founded on September 25, 2015 and is headquartered in Anseong, South Korea. | Health Technology |
- Stock Market
- Insiders
- Gwang-Cheol Park
- Experience
